Oncology Molecular Diagnostics Market 2015 - 2019 is a global report that calculates the revenue generated through the sales of diagnostics assay kits and instruments for cancers, which include Breast, Colorectal, Prostate and Others (including lung and cervical cancers).

Pune, Maharastra -- (SBWire) -- 09/08/2015 --Global Oncology Molecular Diagnostics Market 2015-2019 Report: Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing.

The Global Oncology Molecular Diagnostics Market 2015-2019 report is a 63 pages report that provides 29 Exhibits to support the research. Browse the report at http://www.rnrmarketresearch.com/global-oncology-molecular-diagnostics-market-2015-2019-market-report.html.

Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.

The analysts forecast global oncology molecular diagnostics market to grow at a CAGR of 17.8% over the period 2014-2019.

Covered in this report
This report covers the current scenario and the growth prospects of the global oncology molecular diagnostics market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of diagnostics assay kits and instruments for cancers, which include:
- Breast
- Colorectal
- Prostate
- Others (including lung and cervical cancers)

The report, Global Oncology Molecular Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Buy a Copy of Report Directly at http://www.rnrmarketresearch.com/contacts/purchase?rname=413736. The Single User License Copy of the Report is US $2500.

Key regions
- APAC
- Europe
- Latin America
- MEA
- North America

Key vendors: Abbott Diagnostics, Becton, Dickinson and Company, QIAGEN and Roche Diagnostics

Other prominent vendors: Agendia, Angsana Molecular and Diagnostics, Asuragen, Autogenomics, Beckman Coulter, bioMérieux, bioTheranostics (Formerly AviaraDx), Cangen Biotechnologies, Cepheid, Diagnocure, Epigenomics, Eragen, EXACT Sciences, Exiqon, GeneNews, Genera Biosystems, Genomic Health, Genomix Biotech, Health Discovery, HTG Molecular, Hologic, Innogenetics, Intergenetics, Kreatech Holding, Myriad Genetics, Nanosphere, NorDiag, Nuvera Biosciences, OncoMethylome Sciences, Orion Genomics, Prediction Sciences, Predictive Biosciences, Rosetta Genomics, SensiGen, Source MDx and Vermillion.

Market driver
- Increase in demand for personalized medicines
- For a full, detailed list, view our report

Market challenge
- Ethical, privacy, and practical issues
- For a full, detailed list, view our report

Market trend
- Advances in mass spectrometry
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?